Bullish Bias Builds as Chevron Stock Taps Another High

Chevron could see even more upgrades and/or price-target hikes going forward

by Josh Selway

Published on Jan 11, 2018 at 10:19 AM

With oil prices rising in recent months to multi-year highs, it's not surprising Chevron Corporation (NYSE:CVX) has been on a strong run since this past July. CVX shares have gained 23.6% in the past six months, and this morning touched a fresh three-year high of $129.95. Let's take a closer look at Chevron stock and this morning's brokerage attention below.

BMO this morning upgraded the energy giant to "outperform" from "market perform" and lifted its price target to $140 from $120, citing U.S. tax reform and higher oil prices as two reasons for the bullish note. Meanwhile, Wells Fargo boosted its price target to $129 from $117. Shares of CVX were last seen trading up 1.4% at $130.37 as a result.

The security could enjoy more upbeat analyst attention going forward, since half of the brokerages in coverage still rate it just a "hold" or "strong sell." Plus, Chevron is overtaking its average 12-month price target of $129.82.

Options traders have seemingly been betting on more upside. The stock has a 10-day call/put volume ratio of 2.62 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), showing call buying has almost tripled put buying over the past two weeks. This ratio ranks in the 93rd annual percentile, so this type of focus on long calls over puts is quite rare.

It's becoming pricier to target calls over puts, however. This is according to CVX's 30-day implied volatility skew of -1.2%, which is just 1 percentage point from an annual low. Nonetheless, call volume is already accelerated today, with more than 9,000 of the contracts crossing so far -- more than half the average daily volume.

CVX stock price

Stocks to Buy Before a Fed Rate Hike
The central bank is widely expected to hike interest rates on Wednesday
Breaking Down the Quick & Dirty S&P Drop
The SPX fell more than 10% in 50 sessions
Bet on This Medical Device Stock to Break Out
The shares could be poised to break out of recent congestion below $245
From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Former Hedge-Fund Manager Reveals Stunning Research
This stunning research revealed by the former hedge-fund who predicted the last NASDAQ crash could have some Americans thinking twice before hoarding cash.
Inside the Big Moves from Navistar and Rent-A-Center Stocks
Two of today's biggest stock moves are coming from NAV and RCII
Take-Two Levels Up On Analyst Coverage
Shares of TTWO are up after Buckingham Research weighed in
Former Hedge-Fund Manager Reveals Stunning Research
This stunning research revealed by the former hedge-fund who predicted the last NASDAQ crash could have some Americans thinking twice before hoarding cash.